Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection
Clinical trial NCT04994509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04994509
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2024-05-27
- Enrollment
- 5368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.